CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure
Abstract. Invasive pulmonary aspergillosis (IPA) is a lethal infectious disease with high mortality in patients with liver failure. Early recognition of the risk factors prompting earlier diagnosis and treatment may improve the outcomes. Voriconazole is recommended as the first-line drug for IPA, bu...
Saved in:
| Main Authors: | Chuan Shen, Qian Zhao, Ziyue Li, Wei Wang, Yalin Zhao, Lingya Kong, Jing Xie, Caiyan Zhao, Wei Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health - Lippincott Williams Wilkins
2022-04-01
|
| Series: | Infectious Diseases & Immunity |
| Online Access: | http://journals.lww.com/10.1097/ID9.0000000000000036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis
by: Pinar Bakir Ekinci, et al.
Published: (2024-10-01) -
Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China
by: Zhuo Li, et al.
Published: (2025-05-01) -
Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01) -
Population pharmacokinetics and dose optimization of voriconazole in patients with COVID-19-associated pulmonary aspergillosis
by: Hui Wang, et al.
Published: (2025-04-01) -
Observational study of the recent efficacy and economy of itraconazole vs. voriconazole in perioperative pulmonary aspergillosis
by: Peng Chen, et al.
Published: (2025-04-01)